Autologous Bone Marrow-Derived CD34+, CD133+, and CD271+ Stem Cell Transplantation for Retinitis Pigmentosa

Clinical trial NCT02709876 · UNKNOWN

Trial details

NCT number: NCT02709876
Sponsor: Stem Cells Arabia
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Retinitis Pigmentosa

Start date: 2014-04-01
Primary completion: 2020-09-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.